SEC 13F Intelligence

Foresite Capital Management IV, LLC / ASND

Foresite Capital Management IV, LLC’s Ascendis Pharma A/S Position

Does Foresite Capital Management IV, LLC own Ascendis Pharma A/S (ASND)? Not currently — the last reported position was 69.0K shares worth $10M in Q4 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$10M
Q4 2019
Shares
69.0K
% of Portfolio
+4.14%
Quarters Held
4
position exited

Position History ASND

Reported value by quarter
Q1 ’19: $29MQ1 ’19Q2 ’19: $28MQ2 ’19Q3 ’19: $24MQ3 ’19Q4 ’19: $10MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 201969.0K$10M+4.14%
Q3 2019245.4K$24M+7.64%
Q2 2019245.4K$28M+7.99%
Q1 2019245.4K$29M+10.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of ASND.